BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38164276)

  • 1. Carcinogenic Role and Clinical Significance of Histone H3-H4 Chaperone Anti-silencing Function 1 B (ASF1B) in Lung Adenocarcinoma.
    Song C; Song Y; Wan X; Zhao Z; Geng Q
    J Cancer; 2024; 15(1):218-231. PubMed ID: 38164276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and
    Wu L; Jie B
    Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types.
    Zhang W; Gao Z; Guan M; Liu N; Meng F; Wang G
    Front Oncol; 2021; 11():731547. PubMed ID: 34568067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.
    Zhang S; Xu L; Feng J; Tan D; Zhu Y; Hou J; Li W; Lv K; Wang W; Jiang L; Jiao M; Guo H
    Front Genet; 2022; 13():842351. PubMed ID: 35360875
    [No Abstract]   [Full Text] [Related]  

  • 5. Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.
    Paul PK; Rabaglia ME; Wang CY; Stapleton DS; Leng N; Kendziorski C; Lewis PW; Keller MP; Attie AD
    Cell Cycle; 2016 Dec; 15(23):3191-3202. PubMed ID: 27753532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of
    Feng Z; Zhang J; Zheng Y; Wang Q; Min X; Tian T
    Per Med; 2021 Mar; 18(2):115-127. PubMed ID: 33576264
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma.
    Jiangqiao Z; Tao Q; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z; Tianyu W
    Biochem Biophys Res Commun; 2019 Mar; 511(1):165-172. PubMed ID: 30777326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
    Hu X; Zhu H; Zhang X; He X; Xu X
    Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.
    Han G; Zhang X; Liu P; Yu Q; Li Z; Yu Q; Wei X
    Int J Oncol; 2018 Nov; 53(5):2056-2066. PubMed ID: 30132513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers.
    Chen Y; Zhou W; Gong Y; Ou X
    Prz Gastroenterol; 2023; 18(3):249-265. PubMed ID: 37937108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc.
    Zhang M; Zhang L; Zhou M; Wang E; Meng B; Li Q; Wang X; Wang Y; Li Q
    Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36416310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma.
    Qiu W; Wu X; Shi H; Liu B; Li L; Wu W; Lin J
    Front Oncol; 2022; 12():678025. PubMed ID: 35174076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.
    Corpet A; De Koning L; Toedling J; Savignoni A; Berger F; Lemaître C; O'Sullivan RJ; Karlseder J; Barillot E; Asselain B; Sastre-Garau X; Almouzni G
    EMBO J; 2011 Feb; 30(3):480-93. PubMed ID: 21179005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct role of histone chaperone Asf1a and Asf1b during fertilization and pre-implantation embryonic development in mice.
    Wang X; Wang L; Dou J; Yu T; Cao P; Fan N; Borjigin U; Nashun B
    Epigenetics Chromatin; 2021 Dec; 14(1):55. PubMed ID: 34906203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between
    Zhang Z; Liu S
    Ann Med; 2023 Dec; 55(1):1111-1122. PubMed ID: 36947060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the histone chaperone ASF1B reduces female reproductive capacity in mice.
    Messiaen S; Guiard J; Aigueperse C; Fliniaux I; Tourpin S; Barroca V; Allemand I; Fouchet P; Livera G; Vernet M
    Reproduction; 2016 May; 151(5):477-89. PubMed ID: 26850882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-silencing function 1B knockdown suppresses the malignant phenotype of colorectal cancer by inactivating the phosphatidylinositol 3-kinase/AKT pathway.
    Yu GH; Gong XF; Peng YY; Qian J
    World J Gastrointest Oncol; 2022 Dec; 14(12):2353-2366. PubMed ID: 36568946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway.
    Wang W; Xiao L; Pan D; Hu L
    Neoplasma; 2022 Mar; 69(2):361-369. PubMed ID: 35103478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer.
    Wang K; Hao Z; Fu X; Li W; Jiao A; Hua X
    Mol Cell Biochem; 2022 Jul; 477(7):1947-1957. PubMed ID: 35362843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation.
    Wu Z; Zhuo T; Li Z; Zhu Y; Wu J; Liang G; Dai L; Wang Y; Tan X; Chen M
    J Cancer; 2023; 14(12):2301-2314. PubMed ID: 37576392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.